The PKCβ isoform inhibitor ruboxistaurin, which is the most studied PKC inhibitor, has shown some positive effects on diabetes and diabetic complications in clinical trials [8], [9], [10]. The gene discussed is PRRT2; the disease is diabetes mellitus.